Document is current
Any future updates will be listed below
-
Authors
Calcat-i-Cervera, Sandra https://orcid.org/0000-0002-2300-7104
Rendra, Erika
Scaccia, Eleonora
Amadeo, Francesco https://orcid.org/0000-0002-3868-2348
Hanson, Vivien
Wilm, Bettina https://orcid.org/0000-0002-9245-993X
Murray, Patricia https://orcid.org/0000-0003-1316-148X
O’Brien, Timothy
Taylor, Arthur https://orcid.org/0000-0003-2028-6694
Bieback, Karen https://orcid.org/0000-0003-2621-0703
-
Funding
Funding for this research was provided by:
H2020 European Research Council (813839)
Ruprecht-Karls-Universität Heidelberg
- License Information
-
More Information
Article History
Received: 30 November 2022
Accepted: 20 April 2023
First Online: 4 May 2023
Declarations
:
: A-MSCs from lipoaspirates (healthy donors of both gender in a range of age 47–25 years) were processed in Heidelberg after obtaining informed consent (Mannheim Ethics Commission; vote number 2006-192NMA). BM-MSCs provided by Galway were isolated from bone marrow aspirates (healthy young male donors) purchased from Lonza (Basel, Switzerland), and UC-MSCs with informed consent obtained in accordance with the Declaration of Helsinki were sourced from the NHS Blood and Transplant and transferred to the University of Liverpool. All animal procedures were performed under a licence granted under the UK’s Animals (Scientific Procedures) Act 1986 and were approved by the University of Liverpool Animal Welfare and Ethics Research Board.
: Not applicable.
: The authors declare that they have no competing interests. Timothy O’Brien, co-author of this manuscript and Editor-in-Chief of Stem Cell Research & Therapy, declares that he was not involved in the peer review or decision making of this article.
